98 Views

Response to Immunotherapy: Why So Variable?

Sunday, November 6, 2022

Location: On-Demand

CE: .75 credit/contact hour

Speaker(s)

Identify factors that may affect immunotherapy (IO) treatment response
Describe important drug-drug interactions the AP should monitor for in patients receiving IO
Explain the role of PD-L1 and MSI status in guiding treatment decisions
Discuss complex treatment decisions in patients with comorbid conditions such as autoimmune disorders, history of transplant or multiple malignancies